Related Products
Retatrutide 20mg
20mg
Retatrutide 10mg
10mg
GHK-Cu 50mg
50mg
GLOW 70mg
70mg
Related Research News
AlphaValue/Baader Europe Adjusts Bachem Price Target and Estimates Before H1 Results
AlphaValue/Baader Europe has revised its price target and financial estimates for Bachem, a peptide contract development and manufacturing organization (CDMO), ahead of the company's first-half 2026 results. The adjustments reflect updated expectations for the company's performance in the coming reporting period.
EU Calmodulin-Binding Peptide Resins Market Analysis and Forecast 2026
IndexBox has published a new report analyzing the European Union market for calmodulin-binding peptide resins. The analysis covers market size, trends, and forecasts for the region. The report provides detailed insights into production, consumption, trade, and pricing dynamics across EU member states.
Rugiet enters longevity market with peptide therapy offerings
Rugiet has announced its expansion into the longevity sector by offering peptide therapies. The move marks a strategic shift for the company, which previously focused on other health areas. The new peptide-based treatments are designed to address age-related health concerns.